PROCEPT BioRoboticsĀ® Announces First Commercial Aquablation Therapy Procedures in Japan

Go back to PROCEPT BioRoboticsĀ® Announces First Commercial Aquablation Therapy Procedures in Japan
(NASDAQ: PRCT) Delayed: 21.69 +0.60 (2.84%)
Previous Close $21.09    52 Week High
Open $21.10    52 Week Low
Day High $21.86    P/E N/A 
Day Low $21.10    EPS
Volume 117,833